Skip to main content

Table 9 Outcomes predicted by models for one birth cohort in Amr- region

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

  POLYMODa Roxanne CoRoVa
Undiscounted cases    
   Mild 8,989 11,318 12,481
   Moderate 4,760 6,471 5,286
   Severe 496 897 514
   Nosocomial 164 193 263
   Deaths 31 59 50
   Outpatient 5,256 6,471 5,286
   Inpatient (comm. acq.) 496 897 514
Discounted savings    
   Outpatient $181,333 $216,626 $239,534
   Inpatient $330,083 $432,618 $255,186
   Indirect $105,467 $98,697 $78,947
Discounted net costsb (*1000) $293 $ 346-1,127 $ 495-1271
Discounted QALYs    
   Mortality 900 1,662 1,413
   Morbidity 53 66 61
  1. a. Approximations for one cohort from the multi-cohort results; b. Health-care perspective and range given for previous upper and lower vaccine prices if appropriate